Variant report

Variant	nsv437914
Chromosome Location	chr4:21292213-21375817
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr4:21340833-21340873	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr4:21369524-21369702	A549	lung:	n/a	chr4:21369585-21369598 chr4:21369585-21369596 chr4:21369586-21369597
3	CEBPB	chr4:21331895-21332143	HepG2	liver:	n/a	chr4:21331975-21331986
4	CEBPB	chr4:21369419-21369766	HepG2	liver:	n/a	chr4:21369585-21369598 chr4:21369585-21369596 chr4:21369586-21369597
5	CEBPB	chr4:21362771-21363035	A549	lung:	n/a	chr4:21362916-21362927
6	CEBPB	chr4:21331830-21332133	IMR90	lung:	n/a	chr4:21331975-21331986
7	CEBPB	chr4:21362752-21363039	HepG2	liver:	n/a	chr4:21362916-21362927
8	CEBPB	chr4:21346181-21346331	HepG2	liver:	n/a	chr4:21346213-21346224
9	CTCF	chr4:21331240-21331390	BE2_C	brain:	n/a	n/a
10	CTCF	chr4:21330160-21330310	NHEK	skin:	n/a	n/a
11	CTCF	chr4:21314100-21314250	WI-38	lung:	n/a	n/a
12	CTCF	chr4:21314280-21314430	WI-38	lung:	n/a	n/a
13	CTCF	chr4:21310785-21310942	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr4:21328024-21328083	GM20000	blood:	n/a	n/a
15	CTCF	chr4:21361598-21361642	Spleen_OC	spleen:	n/a	n/a
16	CTCF	chr4:21358360-21358510	GM12865	blood:	n/a	n/a
17	CTCF	chr4:21293867-21293884	GM20000	blood:	n/a	n/a
18	CTCF	chr4:21315380-21315530	GM12869	blood:	n/a	chr4:21315423-21315431
19	CTCF	chr4:21359698-21359743	Kidney_OC	kidney:	n/a	n/a
20	E2F4	chr4:21326896-21326959	MCF10A-Er-Src	breast:	n/a	n/a
21	E2F4	chr4:21333176-21333376	MCF10A-Er-Src	breast:	n/a	n/a
22	E2F4	chr4:21327397-21327751	MCF10A-Er-Src	breast:	n/a	n/a
23	EBF1	chr4:21292052-21292381	GM12878	blood:	n/a	chr4:21292223-21292236 chr4:21292223-21292234
24	EBF1	chr4:21292071-21292391	GM12878	blood:	n/a	chr4:21292223-21292236 chr4:21292223-21292234
25	EP300	chr4:21321738-21321997	SK-N-SH_RA	brain:	n/a	n/a
26	EP300	chr4:21321441-21322272	SK-N-SH	brain:	n/a	n/a
27	FOS	chr4:21306261-21306461	MCF10A-Er-Src	breast:	n/a	chr4:21306327-21306338 chr4:21306329-21306341 chr4:21306330-21306340 chr4:21306331-21306340
28	FOS	chr4:21326864-21327221	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr4:21362800-21363111	MCF10A-Er-Src	breast:	n/a	n/a
30	FOS	chr4:21362820-21363020	MCF10A-Er-Src	breast:	n/a	n/a
31	FOS	chr4:21362850-21363082	MCF10A-Er-Src	breast:	n/a	n/a
32	FOS	chr4:21300485-21300529	MCF10A-Er-Src	breast:	n/a	n/a
33	FOS	chr4:21326879-21327221	MCF10A-Er-Src	breast:	n/a	n/a
34	FOS	chr4:21361293-21361593	MCF10A-Er-Src	breast:	n/a	chr4:21361567-21361576
35	FOS	chr4:21306328-21306392	MCF10A-Er-Src	breast:	n/a	chr4:21306329-21306341 chr4:21306330-21306340 chr4:21306331-21306340
36	FOS	chr4:21326978-21327186	MCF10A-Er-Src	breast:	n/a	n/a
37	FOS	chr4:21326887-21327232	MCF10A-Er-Src	breast:	n/a	n/a
38	FOS	chr4:21327436-21327566	MCF10A-Er-Src	breast:	n/a	n/a
39	GATA3	chr4:21300128-21300328	SH-SY5Y	brain:	n/a	n/a
40	GATA3	chr4:21322839-21323144	SH-SY5Y	brain:	n/a	n/a
41	IRF1	chr4:21350894-21350909	K562	blood:	n/a	n/a
42	IRF3	chr4:21324339-21324349	GM12878	blood:	n/a	n/a
43	JUN	chr4:21294570-21294663	H1-hESC	embryonic stem cell:	n/a	n/a
44	JUND	chr4:21305620-21305836	H1-hESC	embryonic stem cell:	n/a	n/a
45	JUND	chr4:21306181-21306485	HepG2	liver:	n/a	chr4:21306327-21306338 chr4:21306329-21306341 chr4:21306329-21306340 chr4:21306330-21306340 chr4:21306331-21306340
46	JUND	chr4:21306077-21306336	H1-hESC	embryonic stem cell:	n/a	n/a
47	MAFF	chr4:21333095-21333267	HepG2	liver:	n/a	chr4:21333156-21333174
48	MAFK	chr4:21333140-21333328	HepG2	liver:	n/a	chr4:21333157-21333172 chr4:21333162-21333173 chr4:21333160-21333174 chr4:21333157-21333173
49	MAFK	chr4:21333004-21333319	HepG2	liver:	n/a	chr4:21333157-21333172 chr4:21333162-21333173 chr4:21333160-21333174 chr4:21333157-21333173
50	MAFK	chr4:21346230-21346372	HepG2	liver:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:21305941-21305991	GM12878	blood:	n/a
2	chr4:21305941-21305991	GM12878	blood:	n/a
3	chr4:21305490-21305540	HEK293	kidney:	embryo
4	chr4:21305941-21305991	HNPCEpiC	eye:	n/a
5	chr4:21305490-21305540	HRCEpiC	kidney:	n/a
6	chr4:21305805-21305855	SK-N-SH_RA	brain:	n/a
7	chr4:21305549-21305599	AG10803	skin:	n/a
8	chr4:21305549-21305599	HCF	heart:	n/a
9	chr4:21305549-21305599	NB4	blood:	n/a
10	chr4:21306048-21306098	HMEC	breast:	n/a
11	chr4:21306048-21306098	HCF	heart:	n/a
12	chr4:21306048-21306098	HRE	kidney:	n/a
13	chr4:21305941-21305991	MCF-7	breast:	n/a
14	chr4:21305941-21305991	Caco-2	colon:	n/a
15	chr4:21305549-21305599	H1-hESC	embryonic stem cell:	embryo
16	chr4:21305490-21305540	Caco-2	colon:	n/a
17	chr4:21306048-21306098	MCF-7	breast:	n/a
18	chr4:21305941-21305991	ProgFib	skin:	n/a
19	chr4:21306051-21306101	A549	lung:	n/a
20	chr4:21305805-21305855	PrEC	prostate:	n/a
21	chr4:21305490-21305540	SK-N-SH	brain:	n/a
22	chr4:21305490-21305540	ovcar-3	ovarian:	n/a
23	chr4:21306048-21306098	HAEpiC	amniotic membrane:	n/a
24	chr4:21305941-21305991	HEEpiC	esophagus:	n/a
25	chr4:21306048-21306098	SAEC	small airway:	n/a
26	chr4:21305805-21305855	PANC-1	pancreas:	n/a
27	chr4:21306048-21306098	PFSK-1	brain:	n/a
28	chr4:21306051-21306101	H1-hESC	embryonic stem cell:	embryo
29	chr4:21306048-21306098	Hela-S3	cervix:	n/a
30	chr4:21305490-21305540	HIPEpiC	eye:	n/a
31	chr4:21306051-21306101	SKMC	muscle:	n/a
32	chr4:21306048-21306098	GM12892	blood:	n/a
33	chr4:21305805-21305855	SK-N-MC	brain:	n/a
34	chr4:21305490-21305540	NHDF-neo	bronchial:	n/a
35	chr4:21305549-21305599	T-47D	breast:	n/a
36	chr4:21305549-21305599	MCF-7	breast:	n/a
37	chr4:21305549-21305599	SK-N-SH_RA	brain:	n/a
38	chr4:21306048-21306098	BJ	skin:	n/a
39	chr4:21306048-21306098	AG04449	skin:	fetal
40	chr4:21305490-21305540	MCF-7	breast:	n/a
41	chr4:21305549-21305599	PrEC	prostate:	n/a
42	chr4:21305549-21305599	HIPEpiC	eye:	n/a
43	chr4:21305490-21305540	NHBE	bronchial:	n/a
44	chr4:21305805-21305855	HEEpiC	esophagus:	n/a
45	chr4:21306051-21306101	HMEC	breast:	n/a
46	chr4:21305490-21305540	K562	blood:	n/a
47	chr4:21306051-21306101	NHDF-neo	bronchial:	n/a
48	chr4:21305490-21305540	HNPCEpiC	eye:	n/a
49	chr4:21305805-21305855	HCF	heart:	n/a
50	chr4:21305490-21305540	HepG2	liver:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:21372485..21375089-chr4:21376184..21378296,2	K562	blood:
2	chr20:61279326..61279889-chr4:21329070..21329892,2	Hela-S3	cervix:
3	chr4:21297051..21299486-chr4:21300587..21302226,2	MCF-7	breast:
4	chr4:21297051..21299486-chr4:21300587..21302226,2	MCF-7	breast:
5	chr4:21373360..21375651-chr4:21376032..21378469,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PACRGL-2	chr4:21317905-21318108	ENSG00000250243.2
2	lnc-PACRGL-2	chr4:21316899-21316963	ENSG00000250243.2
3	lnc-PACRGL-2	chr4:21306165-21306236	ENSG00000250243.2

Variant related genes	Relation type
KCNIP4	TF binding region
ENSG00000250243	TF binding region
KCNIP4	CpG island
ENSG00000250243	CpG island

Extended variants
information (count: 745 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:745 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4696973	chr4:21292213-21292214	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs540432033	chr4:21292243-21292244	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs112035244	chr4:21292268-21292269	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs80035760	chr4:21292273-21292274	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs532452135	chr4:21292279-21292280	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs557329115	chr4:21292335-21292336	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs553680744	chr4:21292336-21292337	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs531021987	chr4:21292347-21292348	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs145909335	chr4:21292352-21292353	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs188556293	chr4:21292365-21292366	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs534856848	chr4:21292398-21292399	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs138847960	chr4:21292403-21292404	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs370437930	chr4:21292428-21292429	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs558872237	chr4:21292456-21292457	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs571816205	chr4:21292484-21292485	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs115876359	chr4:21292498-21292499	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs185828198	chr4:21292529-21292530	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs574942268	chr4:21292573-21292574	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs535934470	chr4:21292577-21292578	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs7438711	chr4:21292588-21292589	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs7438796	chr4:21292589-21292590	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs60195094	chr4:21292651-21292652	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs147894990	chr4:21292713-21292714	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs572915474	chr4:21292718-21292719	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs540018606	chr4:21292820-21292821	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs55719309	chr4:21292974-21292975	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs565121880	chr4:21292984-21292985	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs116090729	chr4:21301183-21301184	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs187717669	chr4:21301207-21301208	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs192566137	chr4:21301209-21301210	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs547334794	chr4:21301251-21301252	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs77014502	chr4:21301314-21301315	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs533897704	chr4:21301334-21301335	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs558562601	chr4:21301346-21301347	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs570588832	chr4:21301347-21301348	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs182162591	chr4:21301348-21301349	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs28735547	chr4:21301349-21301350	Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs187549531	chr4:21301381-21301382	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs542410507	chr4:21301404-21301405	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs145687521	chr4:21301460-21301461	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs370250082	chr4:21301475-21301476	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs10516379	chr4:21301492-21301493	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs545801766	chr4:21301507-21301508	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs2007762	chr4:21301546-21301547	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs192796771	chr4:21301556-21301557	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs184754247	chr4:21301562-21301563	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs374189072	chr4:21301574-21301575	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs561830877	chr4:21301583-21301584	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs189859803	chr4:21301621-21301622	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs191926076	chr4:21301662-21301663	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Breast cancer	17133270	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Ovarian cancer	17908972	CNVD
Olfactory neuroblastoma	18408657	CNVD
Burkitt''s lymphoma	20823134	CNVD
Burkitt''s lymphoma	19759907	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	22522925	CNVD
Breast cancer	22737080	CNVD
Pancreatic cancer	17952125	CNVD
Cancer	22183965	CNVD
Gastric cancer	16891809	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:156 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:21291200-21292800	Enhancers	Ovary	ovary
2	chr4:21291800-21292400	Enhancers	Fetal Lung	lung
3	chr4:21292200-21292600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
4	chr4:21292200-21293000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
5	chr4:21292400-21292600	Bivalent Enhancer	Fetal Lung	lung
6	chr4:21292400-21292800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
7	chr4:21301200-21301600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr4:21301600-21305200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
9	chr4:21303800-21304200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
10	chr4:21303800-21304200	Active TSS	Brain Germinal Matrix	brain
11	chr4:21303800-21304400	Enhancers	H1 Cell Line	embryonic stem cell
12	chr4:21304000-21304200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
13	chr4:21304000-21305200	Enhancers	HUES48 Cell Line	embryonic stem cell
14	chr4:21304200-21304800	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr4:21304200-21305400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
16	chr4:21304200-21305400	Weak transcription	Brain Germinal Matrix	brain
17	chr4:21304200-21305600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
18	chr4:21304400-21305000	Enhancers	iPS-20b Cell Line	embryonic stem cell
19	chr4:21304400-21305400	Weak transcription	H1 Cell Line	embryonic stem cell
20	chr4:21304600-21304800	Enhancers	HUES64 Cell Line	embryonic stem cell
21	chr4:21304600-21305400	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
22	chr4:21304600-21305400	Enhancers	Brain Hippocampus Middle	brain
23	chr4:21304800-21305000	Enhancers	iPS-15b Cell Line	embryonic stem cell
24	chr4:21304800-21305400	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr4:21304800-21305400	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
26	chr4:21305000-21305200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
27	chr4:21305000-21305200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
28	chr4:21305000-21305400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
29	chr4:21305000-21306400	Active TSS	Brain Anterior Caudate	brain
30	chr4:21305200-21305400	Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
31	chr4:21305200-21305400	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
32	chr4:21305200-21305400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
33	chr4:21305200-21306000	Active TSS	Brain Inferior Temporal Lobe	brain
34	chr4:21305200-21306400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
35	chr4:21305400-21305600	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
36	chr4:21305400-21305600	Flanking Active TSS	H1 Cell Line	embryonic stem cell
37	chr4:21305400-21305600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr4:21305400-21305600	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr4:21305400-21305600	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
40	chr4:21305400-21305600	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
41	chr4:21305400-21305600	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
42	chr4:21305400-21305600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
43	chr4:21305400-21305600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
44	chr4:21305400-21305600	Flanking Active TSS	Brain Hippocampus Middle	brain
45	chr4:21305400-21306200	Active TSS	Brain Substantia Nigra	brain
46	chr4:21305400-21306400	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
47	chr4:21305400-21306400	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
48	chr4:21305400-21306400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
49	chr4:21305400-21306400	Active TSS	Brain Angular Gyrus	brain
50	chr4:21305400-21306400	Active TSS	Brain Cingulate Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links